Keyword: Lucentis


Ophthotech’s anti-PDGF med fails late-stage combo tests in wet AMD

Ophthotech has seen its share price decimated after it announced over the weekend that its big hope, and what much of its financing has been centered around in recent years, failed to help wet AMD patients see better when used with Novartis’ blockbuster VEGF med Lucentis (ranibizumab).